Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burkina Faso
Burkina Faso: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 91.0% in 2025. β Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burkina Faso, 2008β2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Burkina Faso stood at 91.0%. That is the highest value across all 18 years on record.
That represents a change of unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Burkina Faso peaked at 91.0% in 2014 and was at its lowest, 0.0%, in 2008.
Burkina Faso ranks 59th of 192 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 54.6% | 0.0% | 91.0% | 10 |
| 2020s | 86.8% | 66.0% | 91.0% | 6 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Heat deaths vs projected death rates 1,142 (2090)
- Un projection of annual infant deaths 13,085 (2100)
- Population, male, annual growth rate 2.25 % change on previous year (2025)
- Population, male, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population, male, per capita 0.4982 units per person (2025)
- Deaths in armed conflicts by country 793 (2026)
- Deaths in armed conflicts by region 793 (2026)
- Age population, age 25, male, interpolated 203,470 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Burkina Faso?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Burkina Faso was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Burkina Faso?
- The highest recorded value was 91.0% in 2014.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Burkina Faso?
- The lowest recorded value was 0.0% in 2008.
- How does Burkina Faso rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Burkina Faso ranks 59th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Burkina Faso?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).